More evidence why the product labeling for low-dose vaginal estrogen should be changed?

911 Why the product labeling for low-dose vaginal estrogen should be changed JoAnn E. Manson, MD, DrPH, NCMP, Steven R. Goldstein, MD, NCMP, Risa Kagan, MD, NCMP, Andrew M. Kaunitz, MD, NCMP, James H. Liu, MD, JoAnn V. Pinkerton, MD, NCMP, Robert W. Rebar, MD, Peter F. Schnatz, DO, NCMP, Jan L. Shifren, MD, NCMP, Cynthia A. Stuenkel, MD, NCMP, Margery L.S. Gass, MD, NCMP, Wulf H. Utian, MB Bch, PhD, DSc(Med), for the Working Group on Women’s Health and Well-Being in Menopause